MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • 2025 International Congress

    Decoding Naturalistic Movement for Adaptive Deep Brain Stimulation in Parkinson’s Disease

    D. Lawrence, P. Starr, S. Little (San Francisco, USA)

    Objective: To demonstrate the proof-of-concept of a closed-loop deep brain stimulation (DBS) policy designed to reduce slowness in Parkinson’s disease (PD) by increasing stimulation amplitudes…
  • 2025 International Congress

    Neuroprotective Effects of Co-Administered Hesperetin and Resveratrol Nanoparticles on Oxidative Stress and Neurobehavioral Deficits in Parkinson’s Disease

    R. Rajput, S. Verma (Agra, India)

    Objective: This study aimed to evaluate the therapeutic potential of solid lipid nanoparticles (SLNs) containing hesperetin (HE-SLN), resveratrol (RE-SLN), and their co-administration (HE-RE-SLN) in combating…
  • 2025 International Congress

    Therapeutic Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    A. Badran, M. Gbreel (Cairo, Egypt)

    Objective: To assess the safety and effectiveness of GLP-1 RAs in patients with PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by…
  • 2025 International Congress

    Perinatal Dioxin Exposure and Dopaminergic Vulnerability in the Development of Motor Dysfunction Sequelae

    N. Choudhury, S. Shugar, B. Carr (Gainesville, USA)

    Objective: To investigate the impact of dioxins on movement disorder development and the mechanisms increasing vulnerability to future motor dysfunction. Background: Dioxins are persistent organic…
  • 2025 International Congress

    Single- and Multi-Unit Activity in STN Provides Enhanced Insight into Speech-Related Neural Dynamics in Parkinson’s Patients

    Z. Jourahmad, A. Rohl, J. Greenlee (Iowa City, USA)

    Objective: We aimed to elucidate neural representations in local field potentials (LFP) and single- and multi-unit activity of subthalamic nucleus (STN) neurons during speech tasks,…
  • 2025 International Congress

    Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation

    R. Khamishon, K. Devlin, B. Advisory Board, K. Kang, L. Currens, E. Lu, S. Phelan, E. Choi, S. Willoughby, A. Pantelyat, K. Mills (Baltimore, USA)

    Objective: To describe methodological considerations related to stakeholder engagement in community-based participatory research (CBPR) to create a dance and music-based program (DMBP) for people with…
  • 2025 International Congress

    Daily Activity Analysis of Parkinson’s Disease Using Machine Learning with 3D Poses

    KD. Kim, S. Lyu, T. Dunn (Durham, USA)

    Objective: This study aims to find a digital behavioral marker Parkinson’s disease (PD) in activities of daily living via machine learning (ML) analysis of 3D…
  • 2025 International Congress

    Dose Optimization of Foslevodopa/Foscarbidopa: Post Hoc Analysis of Study Completers

    J. Aldred, M. Bouchard, D. Kern, P. Mir, L. Bergmann, R. Gupta, M. O'Meara, J. Samuelsson, B. Bergmans (Spokane, USA)

    Objective: To describe dose optimization, efficacy, and safety of foslevodopa/foscarbidopa (LDp/CDp) in patients with advanced Parkinson’s disease (PwaPD) who completed a 52-week open-label study. Background:…
  • 2025 International Congress

    Characterization of neuronal exosomes purified from plasma of Parkinson’s Disease Chilean patients

    V. Urbina, C. Aguilera, E. Larraechea, D. Sepulveda, R. Vidal (Santiago, Chile)

    Objective: The diagnosis of PD is usually late and has only palliative treatments that seek to slow the progression of motor symptoms. These characteristics make…
  • 2025 International Congress

    Automatic Intelligibility Rating in Parkinson’s Disease: A Multilingual Approach

    T. Thies, F. Dörr, A. König, N. Linz, M. Barbe, J. Orozco-Arroyave, J. Rusz, J. Tröger (Saarbrücken, Germany)

    Objective: To investigate the validity and robustness of an automatically generated intelligibility score in Parkinson’s disease (PD) across multiple languages. Background: 90% of people with…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley